Clinical Microbiology and Infection最新文献

筛选
英文 中文
Which trial do we need? A randomized controlled trial comparing 7 vs. 14 days of antibiotic therapy for the treatment of urinary tract infection with systemic signs and symptoms in male patients. 我们需要哪个试验?一项随机对照试验比较7天和14天抗生素治疗泌尿道感染的系统性体征和症状的男性患者。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-27 DOI: 10.1016/j.cmi.2025.05.025
Johan Van Laethem, Marco Moretti, Ineke Aerts, Pieter-Jan Cortoos
{"title":"Which trial do we need? A randomized controlled trial comparing 7 vs. 14 days of antibiotic therapy for the treatment of urinary tract infection with systemic signs and symptoms in male patients.","authors":"Johan Van Laethem, Marco Moretti, Ineke Aerts, Pieter-Jan Cortoos","doi":"10.1016/j.cmi.2025.05.025","DOIUrl":"10.1016/j.cmi.2025.05.025","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144181070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and management of Candida endophthalmitis and chorioretinitis. 念珠菌眼内炎和脉络膜视网膜炎的诊断和治疗。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-27 DOI: 10.1016/j.cmi.2025.05.028
Nitipong Permpalung, Sarah Sedik, Peter G Pappas, Martin Hoenigl, Luis Ostrosky-Zeichner
{"title":"Diagnosis and management of Candida endophthalmitis and chorioretinitis.","authors":"Nitipong Permpalung, Sarah Sedik, Peter G Pappas, Martin Hoenigl, Luis Ostrosky-Zeichner","doi":"10.1016/j.cmi.2025.05.028","DOIUrl":"10.1016/j.cmi.2025.05.028","url":null,"abstract":"<p><strong>Background: </strong>Candida endophthalmitis (CE) and chorioretinitis are uncommon but potentially devastating complications of candidemia, associated with significant risks of vision loss and long-term morbidity. Effective management relies on timely diagnosis and targeted antifungal therapy. However, diagnostic and therapeutic approaches are hindered by inconsistent guidelines, limited evidence, and variations in clinical practice.</p><p><strong>Objectives: </strong>This review synthesizes current knowledge on CE and chorioretinitis to provide a comprehensive framework for clinicians. It addresses diagnostic challenges, including ophthalmoscopy, imaging, and microbiological diagnostics, and therapeutic strategies such as systemic and intravitreal antifungal therapies, surgical interventions, and serial ophthalmic evaluations.</p><p><strong>Sources: </strong>An extensive literature search was conducted using PubMed, Embase, and Scopus, with a focus on epidemiology, pathogenesis, diagnostics, treatment, and outcomes. Guidelines from the Infectious Diseases Society of America, European Confederation for Medical Mycology, and American Academy of Ophthalmology were reviewed.</p><p><strong>Content: </strong>The prevalence of CE among patients with candidemia has increased from 1.8% in the pre-echinocandin era to 2.1% after the introduction of echinocandins. Diagnosis relies primarily on indirect ophthalmoscopy, the reference standard for retinal visualization. In selected cases, optical coherence tomography or fundus photography may support lesion assessment. Microbiological confirmation via vitreous sampling remains definitive but is often limited by low organism burden. Emerging diagnostics-such as clustered regularly interspaced short palindromic repeats-based fungal DNA assays-have shown promise. Although artificial intelligence-assisted imaging tools are established in other retinal diseases, they have not yet been validated for Candida ocular infections. Fluconazole and voriconazole remain first-line systemic therapies, with intravitreal injections and vitrectomy reserved for severe cases.</p><p><strong>Implications: </strong>Improving outcomes in CE requires harmonized screening protocols, timely access to ophthalmologic care, and multidisciplinary collaboration. Future research should aim to refine diagnostic algorithms, define optimal treatment durations, clarify the role of emerging diagnostics, and leverage telemedicine and imaging technologies to improve early detection and longitudinal monitoring.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144180696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic resistance in Türkiye: what has been done and what needs to be done urgently? <s:1>基耶病毒的抗生素耐药性:已经做了什么,迫切需要做什么?
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-27 DOI: 10.1016/j.cmi.2025.05.019
Özlem Alhan, Hasan Selçuk Özger, Onur Karatuna, Özlem Kurt Azap, Bahar Madran, Şiran Keske, Güle Çınar, İrem Akdemir, Önder Ergönül
{"title":"Antibiotic resistance in Türkiye: what has been done and what needs to be done urgently?","authors":"Özlem Alhan, Hasan Selçuk Özger, Onur Karatuna, Özlem Kurt Azap, Bahar Madran, Şiran Keske, Güle Çınar, İrem Akdemir, Önder Ergönül","doi":"10.1016/j.cmi.2025.05.019","DOIUrl":"10.1016/j.cmi.2025.05.019","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144180863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project. 意大利一项大型危重患者队列中呼吸相关肺炎的发病率、微生物学和死亡率来自PROSAFE项目的结果。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-27 DOI: 10.1016/j.cmi.2025.05.026
Marta Colaneri, Giorgia Montrucchio, Giovanni Scaglione, Gianpaola Monti, Giovanni Tricella, Camilla Genovese, Fulvio Agostini, Francesca Dore, Bruno Viaggi, Luca Brazzi, Valentina Sanna, Andrea Gori, Emanuele Palomba, Martina Offer, Stefano Finazzi
{"title":"Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project.","authors":"Marta Colaneri, Giorgia Montrucchio, Giovanni Scaglione, Gianpaola Monti, Giovanni Tricella, Camilla Genovese, Fulvio Agostini, Francesca Dore, Bruno Viaggi, Luca Brazzi, Valentina Sanna, Andrea Gori, Emanuele Palomba, Martina Offer, Stefano Finazzi","doi":"10.1016/j.cmi.2025.05.026","DOIUrl":"10.1016/j.cmi.2025.05.026","url":null,"abstract":"<p><strong>Objectives: </strong>Despite preventive measures, ventilator-associated pneumonia (VAP) remains the most common healthcare-associated infection in the intensive care unit (ICU). VAP's striking incidence and impact are a leading cause of morbidity and prolonged ICU stay. This study focused on the characteristics and outcomes of patients diagnosed with ICU-acquired VAPs in Italian ICUs.</p><p><strong>Methods: </strong>Data were drawn from the PROSAFE network, a prospective multicentric observational project conducted across 192 Italian ICUs (2014-2023). Clinical data were recorded following the European Centre for Disease Prevention and Control VAP definitions. The incidence rate was estimated, and multivariable logistic regression identified ICU mortality risk factors.</p><p><strong>Results: </strong>The patients admitted to the included ICUs were 402 085. Among 122 430 classified at risk for VAP because of invasive mechanical ventilation (IMV) ≥48 hours, a total of 11 978 VAP cases were identified, corresponding to a prevalence of 9.8%. The incidence rate of VAP was 10.47 cases per 1 000 ventilator days (95% CI: 10.28-10.66). Patients with VAP exhibited prolonged ICU stays (median: 23 days, Q1-Q3: 15-36) and high mortality (30.0%). Microbiological profiling of VAP identified Pseudomonas spp. (21.0%), Staphylococcus aureus (20.2%), and Klebsiella spp. (20.1%) as the predominant pathogens. The logistic regression showed that older age, chronic liver and kidney diseases, multidrug-resistant organisms, and Acinetobacter spp. aetiology and duration of ICU stay before VAP were significantly associated with higher mortality.</p><p><strong>Discussion: </strong>While confirming the overall high mortality of patients undergoing IMV, our findings highlight the significantly prolonged ICU stay in VAP patients, and the influence of multidrug-resistant organisms on VAP-related mortality. These insights emphasize the necessity for effective and timely preventive strategies, as well as the early identification of VAP aetiology.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144180674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: Humans as a potential reservoir for the emerging ST301 Shiga toxin-producing Escherichia coli clones of serotype O80:H2? 人类作为新出现的ST301产志贺毒素的O80:H2型大肠杆菌克隆的潜在宿主?
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-26 DOI: 10.1016/j.cmi.2025.05.018
Frédéric Auvray, Federica Gigliucci, Valeria Michelacci, Gaia Scavia, Laurent Cavalié, Aurélie Cointe, Florence Crombé, Flemming Scheutz, Claire Jenkins, Stefano Morabito, Stéphane Bonacorsi, Eric Oswald
{"title":"Re: Humans as a potential reservoir for the emerging ST301 Shiga toxin-producing Escherichia coli clones of serotype O80:H2?","authors":"Frédéric Auvray, Federica Gigliucci, Valeria Michelacci, Gaia Scavia, Laurent Cavalié, Aurélie Cointe, Florence Crombé, Flemming Scheutz, Claire Jenkins, Stefano Morabito, Stéphane Bonacorsi, Eric Oswald","doi":"10.1016/j.cmi.2025.05.018","DOIUrl":"10.1016/j.cmi.2025.05.018","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed accurate diagnosis of emerging disease outbreaks, the example of nodding syndrome. 延迟准确诊断新出现的疾病爆发,例如点头综合症。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-26 DOI: 10.1016/j.cmi.2025.05.024
Robert Colebunders, Amber Hadermann, Charlotte Lubbers, Joseph Siewe Fodjo
{"title":"Delayed accurate diagnosis of emerging disease outbreaks, the example of nodding syndrome.","authors":"Robert Colebunders, Amber Hadermann, Charlotte Lubbers, Joseph Siewe Fodjo","doi":"10.1016/j.cmi.2025.05.024","DOIUrl":"10.1016/j.cmi.2025.05.024","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144173032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: 'Learning from post COVID-19 condition for epidemic preparedness' by Górska et al. 回复:Gorska等人的“从COVID-19后的情况中学习流行病防范”。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-24 DOI: 10.1016/j.cmi.2025.05.020
Hugh R Watson
{"title":"Re: 'Learning from post COVID-19 condition for epidemic preparedness' by Górska et al.","authors":"Hugh R Watson","doi":"10.1016/j.cmi.2025.05.020","DOIUrl":"10.1016/j.cmi.2025.05.020","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144149352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: 'Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia' by Kritsotakis et al. 回复:Kritsotakis等人的“耐碳青霉烯不动杆菌鲍曼菌血症导致的死亡率”。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-23 DOI: 10.1016/j.cmi.2025.04.043
Shouhui Yi
{"title":"Re: 'Mortality due to carbapenem-resistant Acinetobacter baumannii bacteraemia' by Kritsotakis et al.","authors":"Shouhui Yi","doi":"10.1016/j.cmi.2025.04.043","DOIUrl":"10.1016/j.cmi.2025.04.043","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143957178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re: 'Safety of pertussis vaccination in pregnancy and effectiveness in infants' by Kildegaard et al. 回复:Kildegaard等人的“妊娠期百日咳疫苗接种的安全性和婴儿的有效性”。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-23 DOI: 10.1016/j.cmi.2025.04.044
Qinhan Liu, Jun Li, Yaling Li
{"title":"Re: 'Safety of pertussis vaccination in pregnancy and effectiveness in infants' by Kildegaard et al.","authors":"Qinhan Liu, Jun Li, Yaling Li","doi":"10.1016/j.cmi.2025.04.044","DOIUrl":"10.1016/j.cmi.2025.04.044","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143980902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prosthetic joint infection-a complex disease with rising challenges. 假体关节感染-一个复杂的疾病与不断上升的挑战。
IF 10.9 1区 医学
Clinical Microbiology and Infection Pub Date : 2025-05-22 DOI: 10.1016/j.cmi.2025.04.039
Flaminia Olearo, Parham Sendi
{"title":"Prosthetic joint infection-a complex disease with rising challenges.","authors":"Flaminia Olearo, Parham Sendi","doi":"10.1016/j.cmi.2025.04.039","DOIUrl":"10.1016/j.cmi.2025.04.039","url":null,"abstract":"","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143970095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信